Arcadia Biosciences, Inc. (RKDA)
| Market Cap | 69.53M |
| Revenue (ttm) | 1.32M |
| Net Income (ttm) | -19.80M |
| Shares Out | 10.72M |
| EPS (ttm) | -2.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 1 |
| Last Price | $3.24 |
| Previous Close | $3.17 |
| Change ($) | 0.07 |
| Change (%) | 2.21% |
| Day's Open | 3.19 |
| Day's Range | 3.17 - 3.33 |
| Day's Volume | 407,117 |
| 52-Week Range | 2.30 - 6.40 |
Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) shares rose Wednesday as the agricultural biotech group said it had boosted its board with Debbie Carosella, a food industry executive and forme...
DAVIS, Calif., Feb. 24, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food in...
DAVIS, Calif., Dec. 22, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food in...
DAVIS, Calif., Dec. 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food in...
RKDA has had a number of important developments which I review here. They include: A transformative transaction in the HB4 soybean space.
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q3 2020 Results - Earnings Call Transcript
DAVIS, Calif., Nov. 12, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA) today announced a series of strategic transactions with Bioceres Crop Solutions Corp (NYSE: BIOX), includi...
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q2 2020 Results - Earnings Call Transcript
DAVIS, Calif., Aug. 13, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.
DAVIS, Calif., July 30, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.
Chinese Approval Of HB4 Soybeans Could Be A Major Catalyst For Arcadia Biosciences
DAVIS, Calif., July 6, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ing...
Arcadia Biosciences: An Update On Its Hemp/CBD Operations
DAVIS, Calif., May 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ing...
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q1 2020 Results - Earnings Call Transcript
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q4 2019 Results - Earnings Call Transcript
Arcadia Biosciences Inc (NASDAQ: RKDA), a developer of food ingredients and nutritional oils, with some pre-existing hemp assets and a partnership with Shane Victorino, a former MLB player and...
I'm Joining Insiders In Buying Arcadia Biosciences Stock
Arcadia Biosciences, Inc. (RKDA) CEO Matt Plavan on Q3 2019 Results - Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ: RKDA) reported third-quarter revenue of $392,000 on Wednesday, an increase from revenue of $370,000 in the same quarter in 2018.
Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures.
USDA approval of soybean could be a major catalyst longer term for RKDA, potentially generating up to $125M in annual revenues at 60%+ margins.
Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA), announced this week plans for a new sun-grown hemp cultivation and ...
Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, r...
Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Mil...
Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q2 2019 Results - Earnings Call Transcript
Arcadia Biosciences (NASDAQ: RKDA) is expected to announce Tuesday a joint venture with Legacy Ventures Hawaii to grow, extract and sell superior hemp products, Benzinga has learned exclusively.
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for th...
Arcadia Biosciences' (RKDA) CEO Rajendra Ketkar on Q1 2019 Results - Earnings Call Transcript
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q4 2018 Results - Earnings Call Transcript
In July of last year I explained why I wanted to have exposure to the agricultural genome-editing space, and after examining a few pure plays, I then went on to describe why Arcadia Bioscience...
About RKDA
Arcadia Biosciences, a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools foc... [Read more...]
| Industry Agricultural Inputs | IPO Date May 15, 2015 |
| CEO Matthew T. Plavan | Employees 41 |
| Stock Exchange NASDAQ | Ticker Symbol RKDA |
Financial Performance
In 2019, RKDA's revenue was $1.17 million, a decrease of -20.15% compared to the previous year's $1.46 million. Losses were -$28.81 million, 113.7% more than in 2018.
Analyst Forecasts
According to 2 analysts, the average rating for RKDA stock is "Buy." The 12-month stock price forecast is 6.52, which is an increase of 101.23% from the latest price.